Skyhawk news

Browse:

Skyhawk's proprietary platform revolutionizes disease treatment by developing small molecule therapeutics that modify RNA expression

December 16, 2026
The 20 Startups to Watch in Boston in 2020
Below are the 20 Startups to Watch in 2020. Based on factors like funding, partnerships, awards, technology licenses and more
Read
1 min read
November 12, 2026
Skyhawk’s $80M Celgene deal expands remit to autoimmune
Read
1 min read
November 11, 2019
C&EN’s 2019 10 Start-Ups to Watch
Read
4 min read
July 8, 2019
Fattening the bankroll, Bill Haney adds cancer R&D powerhouse Merck to Skyhawk's roster of partners out to drug RNA
Whatever Biogen learned about Skyhawk in the 6 months since it anted up $74 million to get a collaboration going with their R&D team on drugging RNA for neurodegeneration, it must have been a positive experience
Read
2 min read
January 4, 2019
Joining forces with Skyhawk, C4 Therapeutics, Biogen buys more shots on goal on SMA, Alzheimer’s
Read
2 min read